Anne Stern

1.4k total citations
26 papers, 1.2k citations indexed

About

Anne Stern is a scholar working on Molecular Biology, Cancer Research and Microbiology. According to data from OpenAlex, Anne Stern has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Microbiology. Recurrent topics in Anne Stern's work include Protease and Inhibitor Mechanisms (10 papers), Bacterial Infections and Vaccines (9 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Anne Stern is often cited by papers focused on Protease and Inhibitor Mechanisms (10 papers), Bacterial Infections and Vaccines (9 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Anne Stern collaborates with scholars based in Germany, United States and Belgium. Anne Stern's co-authors include Thomas F. Meyer, Peter Nickel, Melissa H. Brown, Rainer Rudolph, Magdalene So, Ulrich Kohnert, Stephan Fischer, Ulrich Martin, Elisabeth Schwarz and Anke Rattenholl and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Molecular Biology.

In The Last Decade

Anne Stern

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Stern Germany 13 507 477 220 182 105 26 1.2k
H Domdey Germany 19 119 0.2× 768 1.6× 210 1.0× 95 0.5× 70 0.7× 35 1.3k
Shintaro Seto Japan 21 426 0.8× 394 0.8× 80 0.4× 448 2.5× 38 0.4× 49 1.3k
Helena Källström Sweden 11 475 0.9× 392 0.8× 154 0.7× 270 1.5× 30 0.3× 15 1.0k
Victoria Rydengård Sweden 16 772 1.5× 622 1.3× 72 0.3× 83 0.5× 112 1.1× 16 1.3k
Katja Koeppen United States 18 268 0.5× 733 1.5× 84 0.4× 143 0.8× 19 0.2× 34 1.1k
Gabriele Döderlein Germany 8 70 0.1× 583 1.2× 198 0.9× 95 0.5× 88 0.8× 8 1.1k
R Lorenzini Italy 22 81 0.2× 810 1.7× 352 1.6× 221 1.2× 303 2.9× 40 1.7k
Dhana G. Gorasia Australia 18 195 0.4× 631 1.3× 234 1.1× 108 0.6× 12 0.1× 30 1.2k
Heinz Hoschützky Germany 20 62 0.1× 537 1.1× 221 1.0× 102 0.6× 27 0.3× 24 1.2k
М. М. Шмаров Russia 18 164 0.3× 330 0.7× 156 0.7× 311 1.7× 11 0.1× 77 962

Countries citing papers authored by Anne Stern

Since Specialization
Citations

This map shows the geographic impact of Anne Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Stern more than expected).

Fields of papers citing papers by Anne Stern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Stern. The network helps show where Anne Stern may publish in the future.

Co-authorship network of co-authors of Anne Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Stern. A scholar is included among the top collaborators of Anne Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Stern. Anne Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kischel, Philippe, Anne Stern, Cécile Van de Weerdt, et al.. (2002). De novo Backbone and Sequence Design of an Idealized α/β-barrel Protein: Evidence of Stable Tertiary Structure. Journal of Molecular Biology. 325(1). 163–174. 55 indexed citations
2.
Rattenholl, Anke, Hauke Lilie, Adelbert Grossmann, et al.. (2001). The pro‐sequence facilitates folding of human nerve growth factor fromEscherichia coliinclusion bodies. European Journal of Biochemistry. 268(11). 3296–3303. 114 indexed citations
3.
Stern, Anne. (2000). Wine and the protection of geographical indications in South Africa. 2000(388). 30–34. 1 indexed citations
4.
Martin, Ulrich, Ulrich Kohnert, Anne Stern, et al.. (1996). Effective thrombolysis by a recombinant Escherichia coli-produced protease domain of tissue-type plasminogen activator in the rabbit model of jugular vein thrombosis. Fibrinolysis and Proteolysis. 10(2). 87–92. 8 indexed citations
5.
Kohnert, Ulrich, et al.. (1996). The recombinant Escherichia coli-derived protease-domain of tissue-type plasminogen activator is a potent and fibrin specific fibrinolytic agent. Fibrinolysis and Proteolysis. 10(2). 93–102. 14 indexed citations
6.
Stern, Anne, et al.. (1995). Identification and characterization of specific sequences encoding pathogenicity associated proteins in the genome of commensalNeisseriaspecies. FEMS Microbiology Letters. 125(2-3). 255–263. 27 indexed citations
7.
Stern, Anne, et al.. (1992). Phylogeny and nucleotide sequence of a 23S rRNA gene fromNeisseria gonorrhoeaeandNeisseria meningitidis. Nucleic Acids Research. 20(17). 4657–4657. 5 indexed citations
8.
Martin, Ulrich, Stephan Fischer, Ulrich Kohnert, et al.. (1992). Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coli. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(1). 108–113. 9 indexed citations
9.
Stockinger, Hannes, Manfred Kubbies, Rainer Rudolph, et al.. (1992). Binding of recombinant variants of human tissue-type plasminogen activator (t-PA) to human umbilical vein endothelial cells. Thrombosis Research. 67(5). 589–599. 6 indexed citations
10.
Kohnert, Ulrich, Rainer Rudolph, Jan H. Verheijen, et al.. (1992). Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Engineering Design and Selection. 5(1). 93–100. 99 indexed citations
11.
Martin, Ulrich, Stephan Fischer, Ulrich Kohnert, et al.. (1991). Pharmacokinetic properties of an escherichia-coli-produced recombinant plasminogen activator (BM 06.022) in rabbits. Thrombosis Research. 62(3). 137–146. 14 indexed citations
12.
Martin, Ulrich, Stephan Fischer, Ulrich Kohnert, et al.. (1991). Coronary Thrombolytic Properties of a Novel Recombinant Plasminogen Activator (BM 06.022) in a Canine Model. Journal of Cardiovascular Pharmacology. 18(1). 111–119. 25 indexed citations
13.
Bhat, Kolari S., Carol P. Gibbs, O Barrera, et al.. (1991). The opacity proteins of Neisseria gonorrhoeae strain MS11 are encoded by a family of 11 complete genes. Molecular Microbiology. 5(8). 1889–1901. 105 indexed citations
16.
Muralidharan, K., Anne Stern, & Thomas F. Meyer. (1987). The control mechanism of opacity protein expression in the pathogenic Neisseriae. Antonie van Leeuwenhoek. 53(6). 435–440. 8 indexed citations
17.
Stern, Anne & Thomas F. Meyer. (1987). Common mechanism controlling phase and antigenic variation in pathogenic Neisseriae. Molecular Microbiology. 1(3). 5–12. 118 indexed citations
18.
Meyer, Thomas F., Rainer Haas, Anne Stern, et al.. (1986). Surface proteins of pathogenic "Neisseria": antigenic variation and conserved epitopes.. PubMed. 3(1-2). 407–14. 5 indexed citations
19.
Haas, Rainer, Peter Nickel, Anne Stern, & Thomas F. Meyer. (1986). Genomic organization of pilus and opacity genes in neisseria genorrhoeae. MPG.PuRe (Max Planck Society). 81–87. 2 indexed citations
20.
Stern, Anne, Peter Nickel, & Thomas F. Meyer. (1985). Molecular Genetics of the Neisseria gonorrhoeae Opacity Protein. MPG.PuRe (Max Planck Society). 132–139. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026